Trial intelligence / Profile preview

Adjuvant Albendazole After Pulmonary Hydatid Cyst Resection

NCT06483880Recruiting

Sponsor
Ain Shams University
Start
Feb 2024
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in pulmonary hydatid cyst (PHC) comparing Albendazole arm with Placebo arm (2 arms). Primary endpoint: Recurrence of pulmonary hydatid disease at 6 months. Started Feb 2024; status: recruiting.

02

Drugs

albendazole
03

Conditions

pulmonary hydatid cyst (PHC)

Beyond the preview

Go deeper on NCT06483880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06483880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call